Fundraising FoxOmos Bio Making pre-cancer treatable
1 known investors
Find your way into Omos Bio Making pre-cancer treatable
Each arrow is one introduction. Sign up to fill in the first one.
470 people can intro you to Thomas
Ask Andrew D. Ive to introduce you to Thomas Caganek
You →Andrew · together at Oxford Entrepreneurs →Thomas
Sign up to find every way you can get introduced to Omos Bio Making pre-cancer treatable
- Your email: who you already know at Omos Bio Making pre-cancer treatable, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Omos Bio Making pre-cancer treatable team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.
Founders & leadership
TC
Thomas CaganekFounderThomas Caganek is a medical doctor trained at Oxford who founded Omos Biosciences, which develops molecular diagnostic tools for analyzing pre-cancer signatures to identify high-risk cases.
Investors · 1
Spacecadet Ventureslisted by Spacecadet VenturesKent County · $100K – $500K
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Omos Bio Making pre-cancer treatable do?
- Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.
- Who founded Omos Bio Making pre-cancer treatable?
- Omos Bio Making pre-cancer treatable was founded by Frederik Heymann Lassen, Thomas Caganek.
- Who are Omos Bio Making pre-cancer treatable's investors?
- Omos Bio Making pre-cancer treatable's investors include Spacecadet Ventures.